Abstract
Purpose We investigate the long-term outcome of patients with prostate cancer treated with noncurative intent. Materials and Methods All 514 prostate cancer patients who died between 1988 and 1991 and who underwent either deferred or immediate hormonal treatment were followed from death until diagnosis. Results In all patients with stage M0 disease at diagnosis the ultimate cancer mortality rate was 50 percent. Among the 65 patients who survived at least 10 years the mortality rate due to prostate cancer was 63 percent. Conclusions Mortality in patients with stage M0 prostate cancer was surprisingly high when followup exceeded 10 years.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
